Muken Ross 4
4 · SOPHiA GENETICS SA · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS CEO Muken Ross Sells 9,838 Shares
What Happened
Muken Ross, CEO of SOPHiA GENETICS SA (SOPH), sold 9,838 shares on July 6, 2026. The reported weighted-average price was $5.22 per share for total proceeds of $51,354. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations arising from recent restricted stock unit (RSU) vestings.
Key Details
- Transaction date: 2026-07-06 (reported on Form 4 filed 2026-07-07). Filing appears timely.
- Price: weighted average $5.22; actual sale prices ranged from $4.97 to $5.43 (see footnote).
- Shares sold: 9,838; total proceeds reported $51,354.
- Shares owned after transaction: not specified in the information provided.
- Notable footnotes:
- F1: Sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan to satisfy tax withholding for RSU vestings on July 2 and July 3, 2026; trades were non‑discretionary.
- F2: Price is a weighted average; Reporting Person can provide details of prices per share upon written request.
Context
These sales were performed to cover tax withholding on vested RSUs and were executed under a pre-established 10b5-1 trading plan, which typically indicates the trades were routine and not discretionary. Such tax-withholding sales are common and not necessarily a signal of CEO sentiment about the company’s stock.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-07-06$5.22/sh−9,838$51,354→ 670,651 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.43, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.